<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2014031717039N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2014-07-30</date_registration>
      <primary_sponsor>Vice chancellor for research, Jahrom University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of Midazolam and Propofol on nausea and vomiting induced during cesarean section with spinal anesthesia</public_title>
      <acronym></acronym>
      <scientific_title>Clinical trial of Comparison of low-dose Midazolam and Propofol on nausea and vomiting induced during operation, in pregnant women undergoing cesarean section with spinal anesthesia</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2013-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>42</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/15774</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Nausea and vomiting.</hc_freetext>
      <i_freetext>Intervention 1: Patients were divided into two groups A and B randomly by Random Allocation software. They did not receive any special medicine before entering operation room.&#13;
Before starting surgery, patients received 7 ml/kg Ringer serum and then While patients got 65  mg Lidocain 5% for spinal anesthesia, group A were injected 1.5mg Midazolam.&#13;
At the end of surgery patients were transferred to  the recovery room. They were kept in recovery room for at least 1 hour. Nausea and vomiting of patients were measured based on their feelings in 1, 3, 5, 10, 15, 30 and 60 minutes after spinal anesthesia by a self-instructive  questionnaire. &#13;
The patients and the investigator did not have any information about the drugs used. Intervention 2: Patients were divided into two groups A and B randomly by Random Allocation software. They did not receive any special medicine before entering operation room.&#13;
Before starting surgery, patients received 7 ml/kg Ringer serum and then While patients got 65  mg Lidocain 5% for spinal anesthesia, group B were injected 2cc (20mg) Propofol.&#13;
At the end of surgery patients were transferred to  the recovery room. They were kept in recovery room for at least 1 hour. Nausea and vomiting of patients were measured based on their feelings in 1, 3, 5, 10, 15, 30 and 60 minutes after spinal anesthesia by a self-instructive  questionnaire. &#13;
The patients and the investigator did not have any information about the drugs used.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Marjan Jaladat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>7414846199, Motahari Street, Jahrom University of Medical Sciences, Jahrom, Fars, Iran</address>
        <city>Jahrom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7414846199</zip>
        <telephone>+98 79133404059</telephone>
        <email>Marjan.Jaladat@gmial.com</email>
        <affiliation>Jahrom University of  Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hassan Zabetian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>7414846199, Motahari Street, Jahrom University of Medical Sciences, Jahrom, Fars, Iran</address>
        <city>Jahrom</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 79 1334 0405</telephone>
        <email>Dr.Jaladat@jums.ac.ir</email>
        <affiliation>Jahrom University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion Criteria: Written formal consent for operation, Pregnant women aged  15 to 60 years old, Class 1 and 2 ASA, Cesarean section candidate, No physical or mental illness, No consumption of Sedative, Antidepressant, Sleeping  or Psychotropic medicine.&#13;
Exclusion Criteria: Weight more than 100 kg, Age more than 60 or less than 15, Drug or alcoholic abusers, Treatment by Anti depressant, sleeping and psychotropic pills,  Inadequate cooperation  with investigator to assess nausea and vomiting after operation, Hospitalization in ICU after operation, Any background of Propofol or Midazolam sensitivity, Need for additional treatment, Becoming ill after surgery, Increased anesthesia level, Respiratory distress, Patients of class 3 and 4 of ASA, Hemodynamic disorders</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>60 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>k91.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Postprocedural disorder of digestive system, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Patients were divided into two groups A and B randomly by Random Allocation software. They did not receive any special medicine before entering operation room.&#13;
Before starting surgery, patients received 7 ml/kg Ringer serum and then While patients got 65  mg Lidocain 5% for spinal anesthesia, group A were injected 1.5mg Midazolam.&#13;
At the end of surgery patients were transferred to  the recovery room. They were kept in recovery room for at least 1 hour. Nausea and vomiting of patients were measured based on their feelings in 1, 3, 5, 10, 15, 30 and 60 minutes after spinal anesthesia by a self-instructive  questionnaire. &#13;
The patients and the investigator did not have any information about the drugs used.</i_keyword>
      <i_keyword>Patients were divided into two groups A and B randomly by Random Allocation software. They did not receive any special medicine before entering operation room.&#13;
Before starting surgery, patients received 7 ml/kg Ringer serum and then While patients got 65  mg Lidocain 5% for spinal anesthesia, group B were injected 2cc (20mg) Propofol.&#13;
At the end of surgery patients were transferred to  the recovery room. They were kept in recovery room for at least 1 hour. Nausea and vomiting of patients were measured based on their feelings in 1, 3, 5, 10, 15, 30 and 60 minutes after spinal anesthesia by a self-instructive  questionnaire. &#13;
The patients and the investigator did not have any information about the drugs used.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Nausea and Vomiting. Timepoint: 1 ,3, 5, 10, 15, 30 and 60 minutes after spinal anesthesia. Method of measurement: Have or not have with the Questionnaire made by Investigator.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Blood pressure. Timepoint: 1, 3, 5, 10, 15, 30 and 60 minutes after spinal anesthesia. Method of measurement: Sphygmomanometer.</sec_outcome>
      <sec_outcome>Pulse. Timepoint: 1, 3, 5, 10, 15, 30 and 60 minutes after spinal anesthesia. Method of measurement: Pulse oximetry.</sec_outcome>
      <sec_outcome>Respiratory Rate. Timepoint: 1, 3, 5, 10, 15, 30 and 60 minutes after spinal anesthesia. Method of measurement: Counting breaths by investigator.</sec_outcome>
      <sec_outcome>O2 Saturation of arterial blood. Timepoint: During surgery and recovery. Method of measurement: Pulse oximetry.</sec_outcome>
      <sec_outcome>Apgar. Timepoint: 1 and 5 minutes after the birth. Method of measurement: Assessment by investigator by Apgar criteria.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research, Jahrom University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2013-05-29</approval_date>
        <contact_name>Ethics Committee of Jahrom  University of Medical Sciences</contact_name>
        <contact_address>7414846199, Motahari Street, Jahrom University of Medical Sciences, Jahrom, Fars, Iran Jahrom  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
